Brent Sabatini, the Senior Vice President and Chief Accounting Officer at Vir Biotechnology, Inc. (NASDAQ:VIR), recently sold 1,562 shares of the company's common stock. According to InvestingPro data ...

All high schools, including Elliot Alternative, offer the design, visual and media arts pathway. Davis, Downey, Gregori and ...

Tether’s acquisition of a minority stake in Juventus broadens its portfolio by incorporating digital assets, AI, and biotech ...

Tether invests in Juventus, driving JUV token growth and expanding blockchain in sports after its EU exit due to stablecoin regulations.

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Cornerstone Research recently issued its 2024 Year in Review report examining recent trends in securities class action filings. For the second year ...

Moderna’s consensus price target has significantly declined from $119.26 to $47.5, indicating a cautious outlook from ...

Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

Health scientists and drug industry executives around the world are on alert after the confirmation of Robert F. Kennedy Jr., who spreads antivaccine misinformation and has often derided the ...